PadCare Labs: Financial Breakdown
Decoding financial health metrics of PadCare Labs
Total Revenue₹2.2 Cr+162%Prev. FY
Total Expenses₹2.7 Cr+166%Prev. FY
Profit After Tax₹-55.0 Lakh-190%Prev. FY
Total Assets₹4.2 Cr+307%Prev. FY
Net Profit Margin-0.2%-14%Prev. FY
FAQs on Financials of PadCare Labs
No. In FY23, PadCare Labs reported a net loss of ₹55.0 Lakh, so it was not profitable.
PadCare Labs's revenue grew 162.7% year-on-year, from ₹83.0 Lakh in FY22 to ₹2.2 Cr+ in FY23.
PadCare Labs's estimated EBITDA for FY23 was ₹-41.0 Lakh, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY23, PadCare Labs posted revenue of ₹2.2 Cr+ (up 162.7% YoY) and a net loss of ₹55.0 Lakh. Explore the full financials of PadCare Labs here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links